Abstract:Primary malignant tumors of bone are extremely rare, accounting for about 0.2% of all cancers.Osteosarcoma is the most common form of primary malignant tumors of bone and accounts for approximately 19% of all malignant tumors of bone. It is the 3rd most common malignant tumor in teenagers, after leukemia and cerebral cancer. Current treatment methods of osteosarcoma mainly include surgical resection, chemotherapy and radiotherapy. The disease-free survival rate has been escalated from <20% prior to the introduction of neoadjuvant chemotherapy to around 60%, and the overall survival rate reaches to 60%-70%. However, tumor metastases frequently occur, which will result in poor prognosis. The pathogenesis of osteosarcoma has not been clearly understood until now. It is important to further study the occurrence and metastasis mechanisms of osteosarcoma and continue searching for therapeutic targets for the improvement of treatment effects. During the last decade, there is a major discovery of small ribonucleic acid ( RNA ) in bioscience, including microRNA ( miRNA ). MiRNA is noncoding small RNA of 18-25 nucleotides that represses translation and cleaves messenger RNA ( mRNA ) by base-pairing to the 3’ untranslated region ( UTR ) of the target genes, so as to regulate the growth, development and differentiation of the organism. Accordingly, miRNA inlfuences numerous cancer-relevant processes such as proliferation, cell cycle control, apoptosis, differentiation, migration, invasion and metabolism. The expressions of most mRNAs may be regulated by miRNAs, and the cancer-related signaling pathways may be profoundly inlfuenced. MiRNAs can function as tumor suppressors and oncogenes. In recent years, the role of miRNA in the pathogenesis and development of osteosarcoma has been gradually revealed by the scholars. A novel approach for investigating the pathogenesis of osteosarcoma has been provided, and meanwhile new hope has been brought for the treatment of osteosarcoma.

MicroRNAs in Osteosarcoma: from Biological Players to Clinical Contributors, a Review

MicroRNAs and Potential Targets in Osteosarcoma: Review

Research progress on the role of micro-ribonucleic acid in osteosarcoma

MicroRNA signatures in osteosarcoma: diagnostic insights and therapeutic prospects

The promising roles of exosomal microRNAs in osteosarcoma: A new insight into the clinical therapy

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

Role of microRNAs in the crosstalk between osteosarcoma cells and the tumour microenvironment

Changes In Microrna Expression In The Mg-63 Osteosarcoma Cell Line Compared With Osteoblasts

The Role of Lncrna and Mirna on the Effects of Occurrence and Development of Osteosarcoma

MicroRNA and Bone Tumor: To Up Date

Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma

MicroRNAs As Biomarkers in the Diagnosis and Treatment of Chondrosarcoma.

Microrna Profiling Identifies Mir-195 Suppresses Osteosarcoma Cell Metastasis By Targeting Ccnd1

Biological Roles of Microrna-140 in Tumor Growth, Migration, and Metastasis of Osteosarcoma in Vivo and in Vitro

Microrna-150 Functions As an Antioncogenic Regulator in Osteosarcoma

The Landscape of microRNAs in Bone Tumor: A Comprehensive Review in Recent Studies

Microrna-200b Acts As a Tumor Suppressor in Osteosarcoma Via Targeting ZeB1

Association of MiRNA and Bone Tumors: Future Therapeutic Inroads

Advancements in Understanding the Role of Circular RNA in Osteosarcoma

Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications

Progress in research on miRNA in osteosarcoma